Breaking News

Cellipont Unveils Plans for Cell Therapy Facility in Houston

Will include state-of-the-art manufacturing, process development, assay development and testing capabilities.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cellipont Bioservices, a cell therapy contract development and manufacturing organization (CDMO), has unveiled plans for a 76,000 square foot commercial-ready manufacturing facility for cell therapies and gene-modified cell therapies. Located in The Woodlands, TX, the facility will include state-of-the-art manufacturing, process development, assay development and testing capabilities redundant with Cellipont’s 26,000 square foot San Diego location. The new facility will be commissioned in phases...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters